PitchBook’s 2026 Healthcare Outlook points to a broad-based rebound across biotech, medtech, and healthtech, fueled by AI-driven productivity gains, a reopening IPO window, and mounting healthcare policy reforms. AI-native drug discovery platforms are showing measurable efficiency gains, and renewed momentum across medtech, Healthtech, and HCIT is driving a new wave of M&A and IPO activity. With valuations normalizing and convergence accelerating between VC-backed healthtech and PE-backed HCIT, 2026 is shaping up to be a compelling healthcare investment environment.
Read the full article: AI Momentum and Tech Convergence Drive Healthcare’s Expected 2026 Rebound //
Source: https://pitchbook.com/news/reports/2026-healthcare-outlook